Ignite Creation Date:
2024-05-06 @ 7:45 PM
Last Modification Date:
2024-10-26 @ 3:13 PM
Study NCT ID:
NCT06125197
Status:
RECRUITING
Last Update Posted:
2024-04-04
First Post:
2023-10-31
Brief Title:
Oncolytic Adenovirus TILT-123 With Pembrolizumab as Treatment for Refractory Non-Small Cell Lung Cancer
Sponsor:
TILT Biotherapeutics Ltd
Organization:
TILT Biotherapeutics Ltd
Organization Data
Organization:
TILT Biotherapeutics Ltd
Class:
INDUSTRY
Study ID:
Tilt-T610
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
TILT Biotherapeutics Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Merck Sharp Dohme LLC | INDUSTRY |